Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

51.68
Delayed Data
As of 4:00pm ET
 +1.71 / +3.42%
Today’s Change
35.72
Today|||52-Week Range
80.00
-34.19%
Year-to-Date

Today’s Trading

Previous close49.97
Today’s open51.04
Day’s range50.29 - 52.16
Volume604,860
Average volume (3 months)532,048
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-65.32%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book29.34

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.70+11.16%
RDUSRadius Health Inc+2.17+6.46%
BLUEbluebird bio Inc+3.05+8.30%
AXONAxovant Sciences Ltd+0.99+8.63%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$1.15
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs